首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Role of nuclear factor-κB and heme oxygenase-1 in the mechanism of action of an anti-inflammatory chalcone derivative in RAW 264.7 cells
【2h】

Role of nuclear factor-κB and heme oxygenase-1 in the mechanism of action of an anti-inflammatory chalcone derivative in RAW 264.7 cells

机译:核因子-κB和血红素加氧酶-1在RAW 264.7细胞中消炎查尔酮衍生物的作用机制中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

class="enumerated" style="list-style-type:decimal">The synthetic chalcone 3′,4′,5′,3,4,5-hexamethoxy-chalcone (CH) is an anti-inflammatory compound able to reduce nitric oxide (NO) production by inhibition of inducible NO synthase protein synthesis. In this work, we have studied the mechanisms of action of this compound.CH (10–30 μM) prevents the overproduction of NO in RAW 264.7 macrophages stimulated with lipopolysaccharide (1 μg ml−1) due to the inhibition of nuclear factor κB (NF-κB) activation.We have shown that treatment of cells with CH results in diminished degradation of the NF-κB–IκB complex leading to inhibition of NF-κB translocation into the nucleus, DNA binding and transcriptional activity.We also demonstrate the ability of this compound to activate NfE2-related factor (Nrf2) and induce heme oxygenase-1 (HO-1).Our results indicate that CH determines a rapid but nontoxic increase of intracellular oxidative species, which could be responsible for Nrf2 activation and HO-1 induction by this chalcone derivative. This novel anti-inflammatory agent simultaneously induces a cytoprotective response (HO-1) and downregulates an inflammatory pathway (NF-κB) with a mechanism of action different from antioxidant chalcones.
机译:class =“ enumerated” style =“ list-style-type:decimal”> <!-list-behavior =枚举前缀-word = mark-type = decimal max-label-size = 0-> 合成查尔酮3',4',5',3,4,5-六甲氧基查尔酮(CH)是一种消炎化合物,能够通过抑制可诱导的NO合酶蛋白质合成来减少一氧化氮(NO)的产生。在这项工作中,我们研究了该化合物的作用机理。 CH(10–30μM)防止了用脂多糖(1μgml -1刺激的)RAW 264.7巨噬细胞中NO的过量产生)是由于抑制了核因子κB(NF-κB)的活化。 我们已经证明,用CH处理细胞会减少NF-κB–IκB复合物的降解,从而导致 我们还证明了该化合物激活NfE2相关因子(Nrf2)并诱导血红素加氧酶-1(HO-1)的能力。 )。 我们的结果表明,CH决定了细胞内氧化物质的快速但无毒增加,这可能是该查尔酮衍生物引起Nrf2活化和HO-1诱导的原因。 这新型抗炎药同时诱导细胞保护反应(HO-1),并通过一种机制下调炎症途径(NF-κB)不同于抗氧化剂查耳酮。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号